Skip to content
by Legal Desire
14 August 2024

Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Yang Yi Lead Clifford Chance Partner M&A, antitrust, intellectual property and equity investment Shanghai
Bai Yong Clifford Chance Partner Not stated Beijing
Dayu Man Clifford Chance Counsel Not stated Beijing
Carolin Kemmner Clifford Chance Counsel Not stated Düsseldorf
Annabel Joschko Clifford Chance Associate Not stated Düsseldorf
Yuling Geng Clifford Chance Counsel Not stated Hong Kong
Michael Yan Clifford Chance Senior associate Not stated Hong Kong
Andrew Epstein Clifford Chance Partner Not stated New York
Jason Parsont Clifford Chance Partner Not stated New York
Matthew Warner Clifford Chance Partner healthcare and US investment New York
Daryl Fairbairn Clifford Chance Counsel Not stated New York
Lauren Rackow Clifford Chance Counsel Not stated New York
Vicki Ye Clifford Chance Associate Not stated New York
Brian Concklin Clifford Chance Partner Not stated Washington, D.C.
Renee Latour Clifford Chance Partner Not stated Washington, D.C.
Elyssa Wenzel Clifford Chance Associate Not stated Washington, D.C.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Keymed Biosciences (Chengdu) Co., Ltd.Sell-side
Counterparties
Belenos Biosciences, Inc. (Buy-side)